United StatesBreaking News

Paul Baiocchi, head of fund sales and strategy at SS&C ALPS Advisors, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." They discuss the ALPS Electrification Infrastructure ETF (ticker: ELFY).

Saxby Chambliss, former US Senator from Georgia (R), former Senate Agriculture, Nutrition and Forestry Committee Chairman (2005-07), former Ranking Member of the Senate Select Committee on Intelligence (2011-12) joined Balance of Power to discuss the Georgia primary race tomorrow and what the voter is really focused on in 2026.

Bloomberg's Isabelle Lee and Vildana Hajric joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." The Roundhill Memory ETF (ticker: DRAM) assets are nearly $10 Billion since launching April 2nd.

Matt Brill, head of North American investment grade credit at Invesco, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." They discuss high-grade credit, inflation's impact on fixed income, and the Invesco Total Return Bond ETF (Ticker: GTO).

Matt Brill, head of North American investment grade credit at Invesco, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." They discuss high-grade credit, inflation's impact on fixed income, and the Invesco Total Return Bond ETF (Ticker: GTO).

A federal jury rejects Elon Musk's claims about OpenAI under Sam Altman and says he waited too long to sue. Musk took Altman to trial saying he went against OpenAI's mission by turning it into a for-profit business. Matthew Schettenhelm of Bloomberg Intelligence has been following the case and has more.

"We've got to get the SpaceX IPO stuff going here pretty soon," Elon Musk said at a tech summit in Israel on Monday. He's looking to raise as much as $75 billion on a valuation of more than $2 trillion. Bloomberg's Anthony Hughes reports.

Ryanair Holdings plc (NASDAQ:RYAAY) reported its finalized, record-breaking financial results for the fiscal year ended March 31, 2026 (FY26), highlighting explosive bottom-line performance, strategic fuel defenses, and significant corporate restructuring.

Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) announced positive chemistry, manufacturing, and controls (CMC) data supporting the late-stage development of its lead antimicrobial candidate, Nu-3.

C3is (NASDAQ:CISS) announced its financial and operational results for the first quarter ended March 31, 2026, delivering substantial bottom-line expansion and enhanced operating leverage.

INNEOVA Holdings (NASDAQ:INEO) announced its audited financial results for the fiscal year ended December 31, 2025, charting a period of transition and operational realignment.

MIAX CEO Thomas Gallagher joins Bloomberg Open Interest to explain why the exchange is betting big on retail futures trading, how mega IPOs like SpaceX could reshape options markets, and why Miami is emerging as "Wall Street South." The conversation also covers Bloomberg's new equity index futures launch and the next phase of MIAX's expansion strategy.